Evaxion A/S (EVAX) income statement
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.25+0.22 (+10.84%)
Close on Nov 20, 2026Market cap $18.77MP/E –Yield –
Evaxion A/S financial ratios
See a number that looks wrong?